{"schema_version":"1","generated_at":"2026-10-28T00:57:29.356Z","data_as_of":null,"url":"https://www.findmykol.com/kol/mark-stoopler","json_url":"https://www.findmykol.com/kol/mark-stoopler/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"mark-stoopler","name":"Mark Stoopler","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"NewYork–Presbyterian Hospital","institution_url":"https://www.findmykol.com/institution/weill-cornell-medicine","city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1295833937","openalex":"A5020667466"},"summary":"Mark Stoopler is an Oncology physician affiliated with NewYork–Presbyterian Hospital. OpenAlex indexes 25 publications with 1,599 citations (h-index 14); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":25,"cited_by_count":1599,"h_index":14,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00998166","title":"A Study of Cisplatin + Pemetrexed + Avastin as First-Line Therapy","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Columbia University","source_url":"https://clinicaltrials.gov/study/NCT00998166","trial_url":"https://www.findmykol.com/trial/NCT00998166"}],"source":"trials"},"payments":{"company_count":5,"program_years":{"first":2021,"last":null},"rows_total":6,"shown":3,"withheld":3,"rows":[{"payer":"Takeda Pharmaceuticals U.S.A., Inc.","program_year":2024,"amount_usd":5656.5,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1295833937"},{"payer":"Amgen Inc.","program_year":2022,"amount_usd":199.09,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1295833937"},{"payer":"Alexion Pharmaceuticals, Inc.","program_year":2022,"amount_usd":45.41,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1295833937"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1295833937","source":"payments"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cancer & immunology","share_pct":89.2,"classes_total":1,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":89.2,"drugs":[{"name":"Tagrisso","share_pct":48.5},{"name":"Erlotinib Hcl","share_pct":40.4},{"name":"Gilotrif","share_pct":11.1}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":10.8,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":10.8,"drugs":[{"name":"Xarelto","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":97.3,"facility_pct":2.7},"source":"medicare"},"publications":{"total":25,"shown":5,"withheld":20,"matched_by":"OpenAlex author record","recent":[{"title":"Central Nervous System Metastases from Primary Lung Carcinoma: Significance of RNA Fusion Testing and Early Versus Late Metastases","year":2025,"journal":"Journal of Personalized Medicine","source_url":"https://doi.org/10.3390/jpm15050181","status":"verified"},{"title":"Impact of trial eligibility criteria on enrollment to KRAS<sup>G12C</sup> inhibitor trials in patients with non-small cell lung cancer.","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.11012","status":"verified"},{"title":"Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial","year":2020,"journal":"The Lancet Oncology","source_url":"https://doi.org/10.1016/s1470-2045(20)30140-6","status":"verified"},{"title":"Characteristics and outcomes of lung cancer in solid organ transplant recipients","year":2020,"journal":"Lung Cancer","source_url":"https://doi.org/10.1016/j.lungcan.2020.06.018","status":"verified"},{"title":"Synchronous Pulmonary Adenocarcinomas","year":2020,"journal":"American Journal of Clinical Pathology","source_url":"https://doi.org/10.1093/ajcp/aqaa023","status":"verified"}],"source":"works"},"contact":{"address_1":"161 FORT WASHINGTON AVENUE","address_2":"ROOM 936","city":"New York","state":"NY","zip":"100323729","phone":"212-305-8230","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1295833937","source":"identity"},"similar":[{"name":"Kevin Clerkin","slug":"kevin-clerkin","institution":"NewYork–Presbyterian Hospital","specialty":"Advanced Heart Failure and Transplant Cardiology","url":"https://www.findmykol.com/kol/kevin-clerkin","json_url":"https://www.findmykol.com/kol/kevin-clerkin/profile.json"},{"name":"Brandon Swed","slug":"brandon-swed","institution":"NewYork–Presbyterian Hospital","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/brandon-swed","json_url":"https://www.findmykol.com/kol/brandon-swed/profile.json"},{"name":"Lawrence Lenke","slug":"lawrence-lenke","institution":"NewYork–Presbyterian Hospital","specialty":"Orthopaedic Surgery","url":"https://www.findmykol.com/kol/lawrence-lenke","json_url":"https://www.findmykol.com/kol/lawrence-lenke/profile.json"},{"name":"Manuel Hidalgo Medina","slug":"manuel-hidalgo-medina","institution":"NewYork–Presbyterian Hospital","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/manuel-hidalgo-medina","json_url":"https://www.findmykol.com/kol/manuel-hidalgo-medina/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":3,"publications":20}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-09-03","provider_certified":"2024-09-03","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}